Kleo Pharmaceuticals' Series B Round

Kleo Pharmaceuticals raised a round of funding on May 23, 2017.

Kleo Pharmaceuticals is a biotech company initially formed on the basis of intellectual property from the Spiegel Lab at Yale University. The company was founded by Dr. David Spiegel and Roy Prieb, an…

Articles about Kleo Pharmaceuticals' Series B Round: